We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlutter Entertainment Regulatory News (FLTR)

Share Price Information for Flutter Entertainment (FLTR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14,935.00
Bid: 14,945.00
Ask: 14,955.00
Change: 60.00 (0.40%)
Spread: 10.00 (0.067%)
Open: 14,995.00
High: 15,015.00
Low: 14,770.00
Prev. Close: 14,875.00
FLTR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Credit Agreement Amendment

15 Mar 2024 14:00

RNS Number : 0992H
Flutter Entertainment PLC
15 March 2024
 

15 March 2024

Flutter Entertainment plc (the "Company")

Credit Agreement Amendment

On March 14, 2024, Flutter Entertainment plc (the "Company") and certain of its subsidiaries entered into the First Incremental Assumption Agreement (the "Assumption Agreement") to the Term Loan A, Term Loan B and Revolving Credit Facility Agreement dated as of November 24, 2023 (as amended, the "Credit Agreement").

After giving effect to the Assumption Agreement, the aggregate principal amount of term B loans outstanding under the Credit Agreement will increase by $514.375 million (the "First Incremental Term B Loans"), which shall be fungible with the existing term B loans outstanding under the Credit Agreement. The First Incremental Term B Loans will:

(i) refinance a corresponding amount of term B loans originally due to mature July 22, 2028 incurred by the Company pursuant to the Term Loan B Agreement dated as of July 29, 2022 with Deutsche Bank AG, New York Branch, acting as the original agent and security agent, and the lenders named therein,

(ii) mature on November 30, 2030,

(iii) bear interest, at the Borrower's option, at a per annum rate equal to either (x) ABR (provided that in no event shall such ABR rate with respect to the First Incremental Term B Loans be less than 1.00% per annum) plus an applicable margin equal to 1.25% (or 1.00% upon the Net First Lien Leverage Ratio decreasing to 2.55:1 or below) or (y) Adjusted Term SOFR (provided that in no event shall such Adjusted Term SOFR rate with respect to the First Incremental Term B Loans be less than 0.50%) plus an applicable margin equal to 2.25% (or 2.00% upon the Net First Lien Leverage Ratio decreasing to 2.55:1 or below), and

(iv) require scheduled amortization payments in quarterly amounts equal to 0.25% of the original principal amount of the First Incremental Term B Loans, payable quarterly, with the balance to be paid at maturity on November 30, 2030.

All other terms of the First Incremental Term B Loans and the Credit Agreement will remain substantially the same except as otherwise amended by the Assumption Agreement.

The foregoing description of the Assumption Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Assumption Agreement, which will be filed with the U.S. Securities and Exchange Commission ("SEC") as Exhibit 10.1 to the Company's Current Report on Form 8-K regarding the Assumption Agreement (the "Current Report"), and is incorporated herein by reference. A copy of the Current Report will be available on the SEC's website at sec.gov and on the SEC Filings page of the Company's website www.flutter.com/investors/sec-filings.

 

Enquiries

Company Secretary: Cosec@flutter.com

Investor Relations: Investor.relations@flutter.com

Press: Corporatemedia@flutter.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBXGDXBXBDGSU
Date   Source Headline
24th Apr 20244:00 pmRNSBlock Listing Interim Review
23rd Apr 202410:00 amRNSNotice of Q1 Results
22nd Apr 20246:25 pmRNSHolding(s) in Company
17th Apr 20246:25 pmRNSPricing of Senior Secured Notes
16th Apr 20249:30 amRNSLaunch of offering of Senior Secured Notes
10th Apr 20246:30 pmRNSHolding(s) in Company
10th Apr 20246:25 pmRNSHolding(s) in Company
4th Apr 20244:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20244:00 pmRNSTotal Voting Rights
2nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
2nd Apr 20242:00 pmRNSPublication of Notice of 2024 AGM
28th Mar 20246:00 pmRNSDirector/PDMR Shareholding
26th Mar 20246:00 pmRNSPublication of Annual Report and Accounts 2023
19th Mar 20245:00 pmRNSNotice of 2023 Preliminary Results
15th Mar 20242:00 pmRNSCredit Agreement Amendment
14th Mar 20242:00 pmRNSBlock Listing Application
1st Mar 20243:00 pmRNSTotal Voting Rights
1st Mar 20242:00 pmRNSDirectorate Change and Board Committee Composition
29th Feb 202411:58 amRNSInformation on IFRS to U.S. GAAP transition
13th Feb 20246:15 pmRNSDirector Declaration
6th Feb 20245:30 pmRNSDirector Declaration
1st Feb 20244:00 pmRNSTotal Voting Rights
29th Jan 202412:30 pmRNSFlutter commences trading on the NYSE
24th Jan 20247:00 amRNSSuspension of Trading on Euronext Listing
18th Jan 20247:00 amRNSQ4 2023 Trading Update
11th Jan 202410:00 amRNSDirectorate Change
2nd Jan 202412:00 pmRNSTotal Voting Rights
19th Dec 20236:00 pmRNSHolding(s) in Company
18th Dec 20235:30 pmRNSHolding(s) in Company
14th Dec 20235:00 pmRNSHolding(s) in Company
12th Dec 20236:30 pmRNSHolding(s) in Company
8th Dec 20234:00 pmRNSHolding(s) in Company
8th Dec 20237:00 amRNSUS listing update and Notice of Q4 trading update
6th Dec 20235:00 pmRNSHolding(s) in Company
1st Dec 20231:30 pmRNSTotal Voting Rights
1st Dec 20231:00 pmRNSHolding(s) in Company
29th Nov 20231:00 pmRNSHolding(s) in Company
28th Nov 20231:06 pmRNSHolding(s) in Company
27th Nov 202310:00 amRNSHolding(s) in Company
24th Nov 202310:30 amRNSHolding(s) in Company
23rd Nov 20235:00 pmRNSHolding(s) in Company
22nd Nov 202312:00 pmRNSHolding(s) in Company
17th Nov 20235:30 pmRNSHolding(s) in Company
16th Nov 202310:00 amRNSHolding(s) in Company
15th Nov 20233:30 pmRNSHolding(s) in Company
15th Nov 20233:00 pmRNSDirector/PDMR Shareholding
9th Nov 20232:00 pmRNSBoard Committee Composition
9th Nov 20237:00 amRNSQ3 2023 Trading Update
3rd Nov 202311:00 amRNSHolding(s) in Company
1st Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.